[111In]QC-P02

N/A

Report date: 2025/11/06 17:59:38

NME

Base Information

Drug Name[111In]QC-P02

Drug Alias Name[111In]QC-P02

ClassificationRadiation-emitting products > Nuclides > Indium > 111InRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionFibroblast activation protein alpha antagonists

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesJohns Hopkins University

China Registration ClassN/A

Develop Information

Active CompaniesJohns Hopkins University

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A